Functional interaction of the immunosuppressant mizoribine with the 14-3-3 protein
about
Modulation of Protein-Protein Interactions for the Development of Novel TherapeuticsConstruction and clarification of dynamic gene regulatory network of cancer cell cycle via microarray data.Mizoribine: a new approach in the treatment of renal disease.14-3-3 proteins: key regulators of cell division, signalling and apoptosis.Methylprednisolone pulse therapy combined with mizoribine following tonsillectomy for immunoglobulin A nephropathy: clinical remission rate, steroid sparing effect, and maintenance of renal function.Dynamic interactions between 14-3-3 proteins and phosphoproteins regulate diverse cellular processes.Comparison of immunosuppressive therapies for IgA nephropathy after tonsillectomy: three-course versus one-course steroid pulse combined with mizoribineMizoribine in the treatment of pediatric-onset glomerular disease.Mizoribine as a safe and effective combined maintenance therapy with prednisolone for anti-neutrophil cytoplasmic antibody-associated vasculitis in a hemodialysis patient.Mizoribine-induced severe hyperglycemia in a patient with microscopic polyangiitis.Arginine methylation of hnRNP K enhances p53 transcriptional activity.Steroid-resistant protein-losing gastroenteropathy complicated with Sjögren's syndrome successfully treated with mizoribine.Comparison of steroid-pulse therapy and combined with mizoribine in IgA nephropathy: a randomized controlled trial.IgG4-Related Tubulointerstitial Nephritis Associated with Membranous Nephropathy in Two Patients: Remission after Administering a Combination of Steroid and Mizoribine.Efficacy of mizoribine followed by low-dose prednisone in patients with idiopathic membranous nephropathy and nephrotic-range proteinuria.Mizoribine therapy combined with steroids and mizoribine blood concentration monitoring for idiopathic membranous nephropathy with steroid-resistant nephrotic syndrome.Maintenance treatment using the purine-synthesis inhibitor mizoribine in a patient with relapsing thrombotic thrombocytopenic purpura.Stabilization of protein-protein interactions in drug discovery.Efficacy of mizoribine and prednisolone combination therapy in adult patients with IgA vasculitis.Study protocol: high-dose mizoribine with prednisolone therapy in short-term relapsing steroid-sensitive nephrotic syndrome to prevent frequent relapse (JSKDC05 trial)Efficacy of weekly mizoribine pulse therapy in refractory lupus nephritis
P2860
Q26775356-4896B7A9-0A77-484F-BDDD-7BFD87DA01C3Q33449310-10F4E7C8-E11F-4D6C-8A5F-80B2D7121340Q33568534-A540F3F5-56C0-442F-A877-E2055E374A61Q34400246-A47194E4-42BB-479E-BCA5-45AFE8E24D3AQ34579691-3662A774-7B6D-4ABC-A855-376E0BBFE4CFQ35787179-E5320563-24D9-4B75-8A53-EF91A952F8C5Q36234400-492366BB-5D76-4FEF-AC7B-C8C56F636E35Q38371253-299EE63F-5AA8-4AB0-AB1C-73B00D86DAF5Q38783573-FDBACF24-5479-49D1-96D2-3B3B2B770EC2Q38783781-DD6A30E8-B34E-438D-A513-129F920A840DQ39983396-D8F0339B-86F9-4ED7-B80A-35A58B01F459Q40793189-6E9F3927-9B3F-44CC-9924-054AF7774BE8Q40982974-5FDD9E07-94F8-439A-BBB3-CB43640F136AQ42727486-9AF1ACC5-12BA-456A-89D0-1038ED1F7B3FQ44420378-8CA692BB-5781-4D99-9303-DDECD15CDC99Q47168526-06510D03-3A5A-4134-A640-E48257010310Q47619730-6B39D741-3CC7-4265-BD58-2F6E57D502AEQ47938743-D9CA2B5B-D00E-4540-89AA-36F15362DFB1Q52709504-0B99F443-9854-4C42-BFF8-D48028239CCFQ57158782-D99745F3-C473-4934-88FB-59952BF5590CQ58204712-0867FD98-E80E-4DC1-A824-A5171C29EC7A
P2860
Functional interaction of the immunosuppressant mizoribine with the 14-3-3 protein
description
2000 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2000
@ast
im Juli 2000 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2000/07/21)
@sk
vědecký článek publikovaný v roce 2000
@cs
wetenschappelijk artikel (gepubliceerd op 2000/07/21)
@nl
наукова стаття, опублікована в липні 2000
@uk
مقالة علمية (نشرت في 21-7-2000)
@ar
name
Functional interaction of the immunosuppressant mizoribine with the 14-3-3 protein
@ast
Functional interaction of the immunosuppressant mizoribine with the 14-3-3 protein
@en
Functional interaction of the immunosuppressant mizoribine with the 14-3-3 protein
@nl
type
label
Functional interaction of the immunosuppressant mizoribine with the 14-3-3 protein
@ast
Functional interaction of the immunosuppressant mizoribine with the 14-3-3 protein
@en
Functional interaction of the immunosuppressant mizoribine with the 14-3-3 protein
@nl
prefLabel
Functional interaction of the immunosuppressant mizoribine with the 14-3-3 protein
@ast
Functional interaction of the immunosuppressant mizoribine with the 14-3-3 protein
@en
Functional interaction of the immunosuppressant mizoribine with the 14-3-3 protein
@nl
P2093
P356
P1476
Functional interaction of the immunosuppressant mizoribine with the 14-3-3 protein
@en
P2093
J. A. Gustafsson
J. Zilliacus
S. Takahashi
P356
10.1006/BBRC.2000.3104
P407
P577
2000-07-21T00:00:00Z